At JPM, debate on Alzheimer’s, family drama in oncology, and a glum CEO

At JPM, debate on Alzheimer’s, family drama in oncology, and a glum CEO

STAT Plus: At JPM, a debate on Alzheimer’s disease, some family drama in oncology, and a beaten-down biotech

By ADAM FEUERSTEIN AND MATTHEW HERPER AND DAMIAN GARDE

ALEX HOGAN/STAT

News and notes from the J.P. Morgan Healthcare Conference, which has been short on blockbuster deals but rich in insights about the future of medicine.

READ MORE